Position in BIO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$32,639,742
+$6,578,011 QoQ
Shares Held
111,167
+18.9% QoQ
Ownership
0.416%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#40
of 399 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Boston Trust Walden Corp holds $522,031,745 across 11 Medical Devices names. BIO ranks #7 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMED |
Globus Medical Inc
|
1,573,361 | $124,311,252 | |
| 2 | SYK |
Stryker Corp
|
293,589 | $92,433,559 | |
| 3 | UFPT |
Ufp Technologies Inc
|
336,278 | $89,157,385 | |
| 4 | STE |
STERIS plc
|
300,450 | $63,265,756 | |
| 5 | ZBH |
Zimmer Biomet Holdings, Inc.
|
518,113 | $44,604,347 | |
| 6 | HAE |
Haemonetics Corp
|
585,148 | $43,886,100 | |
| 7 | BIO |
Bio-Rad Laboratories, Inc.
This page
|
111,167 | $32,639,742 | |
| 8 | EW |
Edwards Lifesciences Corp
|
257,222 | $23,268,301 |
All Filings in BIO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,639,742 | 111,167 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $26,061,731 | 93,495 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $27,220,014 | 89,838 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $26,762,663 | 95,448 | Shares | Defined | 2025-10-17 | |
| No filing history on record for this holder in this stock. | ||||||